CO2 incubators are the primary instrument for in vitro biocompatibility testing of biomaterials, serving as the controlled environment in which living cells are exposed to new polymers, coatings, implant components, and device materials. Every material intended for patient contact must demonstrate biological safety under ISO 10993-5, the international standard for in vitro cytotoxicity testing — and that testing depends entirely on the CO2 incubator maintaining stable, physiologically relevant conditions throughout every phase of the assay. For materials scientists and lab managers working on medical device development, understanding how to configure and validate incubator performance is not a secondary concern; it is a prerequisite for generating defensible, regulatory-grade data.
Why CO2 incubators are central to ISO 10993-5 compliance
ISO 10993-5:2009 requires that mammalian cells be cultured under conditions that replicate physiological temperature, humidity, and CO2 concentration before and during exposure to test materials. The standard specifies incubation at 37°C (±1°C), 5% CO2, and humidity greater than 90% — conditions that CO2 incubators are specifically engineered to deliver. These parameters are not arbitrary; they maintain the pH of bicarbonate-buffered culture media within the narrow range of 7.2 to 7.4 that mammalian cells require for normal proliferation and metabolic function.
All categories of medical device — regardless of contact type or contact duration — require cytotoxicity testing under ISO 10993-1. This makes CO2 incubator performance relevant to an exceptionally broad range of materials labs, from those developing absorbable suture polymers to those evaluating titanium alloy surface coatings. The incubator must bring cell cultures to near-confluent monolayers before material exposure begins, and then maintain identical conditions throughout the extraction or contact period to ensure that any observed cell response reflects the test material and not an environmental variable.
Infrared (IR) CO2 sensors are strongly preferred over thermal conductivity sensors for biocompatibility work. IR sensors maintain calibration more reliably across long experiments and are unaffected by humidity changes — a meaningful advantage in assays that can run for 48 to 72 hours without intervention.
Three cytotoxicity test methods and where incubator precision matters most
ISO 10993-5 describes three distinct contact methods, each placing different demands on the CO2 incubator. Selecting the appropriate method depends on the physical form and intended contact type of the test material, and each method has a distinct stage where incubator precision is most critical.
| Test method | How cells contact the material | Incubator-critical stage | Materials best suited |
|---|---|---|---|
| Extract (elution) | Cells exposed to fluid extract of the material | Extract preparation at 37°C for 24 h; cell exposure for 24–48 h | Leachable coatings, adhesives, degradable polymers |
| Direct contact | Material placed directly on cell monolayer | Entire exposure period (24–72 h) | Films, meshes, solid implant materials |
| Indirect contact (agar overlay) | Material placed on agar layer above cells | Diffusion and exposure period | Low-molecular-weight extractable materials |
For the extract method — the most widely used format — ISO 10993-12:2021 governs sample preparation, specifying an extraction ratio of 3 cm² of material surface area per milliliter of culture medium (or 0.2 g per milliliter for solid materials) for 24 hours at 37°C. Any temperature deviation during this extraction phase directly alters the leachable profile of the material, potentially suppressing the signal for cytotoxic compounds or generating false positives from thermally degraded media components. A CO2 incubator with validated temperature uniformity across all shelf positions is therefore essential for the extraction step as well as for cell exposure.
The endpoint for cytotoxicity under ISO 10993-5 is cell viability: a reduction exceeding 30% relative to the negative control is classified as a cytotoxic response. Cell viability is measured using a tetrazolium reduction assay — most commonly the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, which quantifies cellular metabolic activity in viable cells — or the neutral red uptake (NRU) assay, which measures lysosomal membrane integrity. Both assays require a final incubation step — typically two to three hours at 37°C and 5% CO2 — before colorimetric quantification.
CO2 incubators in scaffold and tissue engineering workflows
Beyond regulatory cytotoxicity screening, CO2 incubators are indispensable to the development of scaffold-based biomaterials used in tissue engineering. Researchers seeding three-dimensional (3D) constructs — made from materials such as poly(ε-caprolactone) (PCL), poly(lactic-co-glycolic acid) (PLGA), collagen hydrogels, and beta-tricalcium phosphate (β-TCP) — depend on CO2 incubators to maintain the physiological conditions under which stem cells, osteoblasts, or endothelial cells will adhere, proliferate, and differentiate on the scaffold structure.
Interested in lab tools and techniques?
For dynamic culture, researchers routinely place bioreactors and rotators directly inside the CO2 incubator, using the incubator chamber itself as the controlled atmosphere for perfused scaffold conditioning. This approach, documented in bone tissue engineering studies using 3D-printed β-TCP scaffolds, allows researchers to simultaneously apply fluid-flow-based mechanical stimulation and maintain the 37°C, 5% CO2 atmosphere required for cell viability. The incubator's internal volume, shelf spacing, and the positioning of its gas circulation system must therefore accommodate external hardware without compromising atmospheric uniformity.
The cell types used in scaffold evaluation vary with the intended clinical application. Osteoblasts and mesenchymal stem cells are standard for bone scaffold studies, where culture periods of seven to 14 days are needed to observe early osteogenic marker expression. Chondrocytes and smooth muscle cells are used for cartilage and vascular graft scaffolds, respectively, and may require longer timelines — sometimes exceeding three weeks — to assess matrix production and cellular integration within the scaffold architecture.
These extended culture periods place a premium on long-term incubator stability. Each experiment depends on the CO2 incubator performing consistently without temperature excursions, CO2 fluctuations, or contamination events that would invalidate weeks of culture work and require the study to restart from scratch.
Tri-gas CO2 incubators — which add independent oxygen control through nitrogen displacement — are increasingly used in scaffold testing where hypoxic conditions are relevant. Wound healing models, cancer invasion assays, and ischemia studies may require oxygen levels between 1% and 5%, conditions that standard CO2 incubators cannot provide. Materials labs evaluating scaffolds for these applications need to specify tri-gas capability at procurement.
The broader context of biomaterial classification, regulatory frameworks, and in vitro testing requirements is covered in Lab Manager's guide to selecting and evaluating biocompatible materials for medical devices.
Incubator variables that compromise biocompatibility data integrity
A 2023 interlaboratory study published in Frontiers in Medical Technology — involving 52 laboratories each testing identical samples according to ISO 10993-5 — found that only 58% of participating labs correctly identified the cytotoxic potential of all test materials. The study identified the percentage of serum supplemented to the extraction medium and the length of cell incubation with the extract as the two most critical sources of variability. Serum supplementation at 10% — rather than the lower concentrations some labs use — substantially increased test sensitivity for materials such as PVC.
These findings have direct implications for incubator management. Elevated serum concentrations alter the thermal and metabolic demands on cultures, making temperature homogeneity across the incubator chamber more consequential. Laboratories should map temperature across all shelf positions using a validated data logger — typically after a 24-hour equilibration period with the incubator loaded to representative capacity — and document the results as part of the instrument qualification record.
CO2 gradient control is equally important. Without an internal circulation fan, CO2 concentration in a loaded incubator can vary from 4.2% near the chamber ceiling to 7.2% near the floor, shifting culture pH outside the 7.2–7.4 window that mammalian cells require. A forced-convection design that actively circulates chamber atmosphere is a requirement — not a premium option — for any incubator used in regulatory biocompatibility work.
The following variables should be documented in the biocompatibility testing standard operating procedure (SOP) for each CO2 incubator used in ISO 10993-5 work:
- Target temperature and acceptable tolerance (37°C ± 1°C)
- CO2 setpoint and sensor type (IR preferred)
- Humidity setpoint (>90% relative humidity)
- Extraction incubation duration (24 hours per ISO 10993-12:2021)
- Serum concentration in extraction medium
- Cell line used (e.g., L-929 murine fibroblasts or human dermal fibroblasts)
- Time from extract preparation to cell exposure (minimize to reduce leachable degradation)
Understanding how the incubator itself can introduce variability is the first step toward generating reproducible biocompatibility data. Detailed guidance on controlling cell culture conditions across CO2 incubator parameters — including sensor calibration, contamination prevention, and door-opening protocols — is covered in Lab Manager's comprehensive guide to CO2 incubator operation and culture condition management.
CO2 incubators as the foundation of materials-to-clinic translation
CO2 incubators for biocompatibility testing are the critical bridge between materials synthesis and clinical application. Every polymer, coating, scaffold, or composite that advances toward regulatory submission must pass through in vitro cytotoxicity evaluation performed inside a calibrated, well-characterized CO2 incubator.
The precision requirements of ISO 10993-5 — 37°C, 5% CO2, humidity above 90%, and tightly controlled extraction conditions — mean that incubator performance is a direct determinant of data quality and regulatory credibility. Labs investing in IR-sensor-equipped incubators with validated uniformity, tri-gas capability, and rigorous SOP documentation are far better positioned to generate reproducible results, avoid false negatives that could advance cytotoxic materials, and satisfy the scrutiny of regulatory submissions.
References
- International Organization for Standardization. (2009). ISO 10993-5:2009: Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity. https://www.iso.org/standard/36406.html
- Nickel, A., & Gruber, S. (2023). Toxic or not toxic? The specifications of the standard ISO 10993-5 are not explicit enough to yield comparable results in the cytotoxicity assessment of an identical medical device. Frontiers in Medical Technology, 5, 1195529. https://doi.org/10.3389/fmedt.2023.1195529
- International Organization for Standardization. (2021). ISO 10993-12:2021: Biological evaluation of medical devices — Part 12: Sample preparation and reference materials. https://www.iso.org/standard/75769.html
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
